Incorporation of other biomarkers like olfactory testing, REM sleep behavior disorder assessment, or alpha-synuclein seed amplification assays could further refine diagnostic accuracy, though current biomarker-based models often suffer from insufficient sample size and low events-per-predictor ratios, limiting their reliability (31). The gene discussed is SNCA; the disease is REM sleep behavior disorder.